TRXC Key Statistics, Chart & Performance
The current stock price of TRXC is 4.08 null. In the past month the price increased by 21.79%. In the past year, price increased by 837.93%.
TRXC Latest News, Press Relases and Analysis
About TRXC
Company Profile
TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.
Company Info
Transenterix Inc
635 DAVIS DRIVE SUITE 300
MORRISVILLE NC 27560
CEO: Anthony Fernando
Phone: 919-765-8400
Transenterix Inc / TRXC FAQ
What does TRXC do?
TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.
Can you provide the latest stock price for Transenterix Inc?
The current stock price of TRXC is 4.08 null. The price decreased by -10.13% in the last trading session.
Does TRXC stock pay dividends?
TRXC does not pay a dividend.
How is the ChartMill rating for Transenterix Inc?
TRXC has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the market capitalization of TRXC stock?
Transenterix Inc (TRXC) has a market capitalization of 582.53M null. This makes TRXC a Small Cap stock.
What is the ownership structure of Transenterix Inc (TRXC)?
You can find the ownership structure of Transenterix Inc (TRXC) on the Ownership tab.
TRXC Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to TRXC. When comparing the yearly performance of all stocks, TRXC is one of the better performing stocks in the market, outperforming 99.13% of all stocks.
TRXC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TRXC. TRXC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
TRXC Financial Highlights
Over the last trailing twelve months TRXC reported a non-GAAP Earnings per Share(EPS) of -1.5699999999999998. The EPS increased by 37.2% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -2150% | ||
| ROA | -73.93% | ||
| ROE | N/A | ||
| Debt/Equity | 0.04 |